This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 May 27;384(21):e81.

doi: 10.1056/NEJMc2104672.

Avacopan for the Treatment of ANCA-Associated Vasculitis

Yusuke Matsuo¹, Yoshishige Miyabe²

Affiliations

PMID: 34042398
DOI: 10.1056/NEJMc2104672

Comment

Avacopan for the Treatment of ANCA-Associated Vasculitis

Yusuke Matsuo et al. N Engl J Med. 2021.

. 2021 May 27;384(21):e81.

doi: 10.1056/NEJMc2104672.

Authors

Yusuke Matsuo¹, Yoshishige Miyabe²

Affiliations

¹ Tokyo Medical and Dental University, Tokyo, Japan matsuo.rheu@tmd.ac.jp.
² Nippon Medical School, Tokyo, Japan.

PMID: 34042398
DOI: 10.1056/NEJMc2104672

No abstract available

PubMed Disclaimer

Comment in

Avacopan for the Treatment of ANCA-Associated Vasculitis. Reply.
Jayne DRW, Merkel PA, Bekker P. Jayne DRW, et al. N Engl J Med. 2021 May 27;384(21):e81. doi: 10.1056/NEJMc2104672. N Engl J Med. 2021. PMID: 34042399 No abstract available.

Comment on

Avacopan for the Treatment of ANCA-Associated Vasculitis.
Jayne DRW, Merkel PA, Schall TJ, Bekker P; ADVOCATE Study Group. Jayne DRW, et al. N Engl J Med. 2021 Feb 18;384(7):599-609. doi: 10.1056/NEJMoa2023386. N Engl J Med. 2021. PMID: 33596356 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations